SMART-CARE had its second plenary progress meeting, to discuss recent achievements towards our common goal to identify cancer predictors. Great progress was reported by the clinical, mass spectrometric and data analysis teams in collecting precious clinical material and establishing workflows to generate and analyse proteomic and metabolomic data. But it was